Veracyte Inc VCYT:NASDAQ

There was a notable level of share sales at Veracyte today, as disclosed in filings with the SEC. Two insiders -- Jesse I Treu, Director, and Evan Jones, Director -- disposed of 1,127,151 shares in the company having a market value of approximately $22,960,674. These are the first insider buy/sell trades in the past 90 days. Adding the most recent activity to this 90-day history indicates insider trades have averaged 563,576 shares per transaction.

Today's Insider Activity

Relative to its peers over the last 90 days, insider buy/sell trading at Veracyte is above the 10-company peer group average. Bio Diagnostics & Testing peer group saw 12 buy/sell trades during this period for an average of 1.2 transactions per company. The number of shares per buy/sell trade for Veracyte insiders was also higher. Within the peer group there were 1,243,053 shares purchased and 57,872 shares sold with company insiders purchasing 131,687 shares on average.

The data sourced in creating and writing in this story eliminates all trading activity reported to the SEC that involves awards, options, exercise of derivative securities, company buy-backs, taxes, gifts, shares acquired via inheritance and tenders or exchange offers.